THEMISMEDThemis Medicare Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹113.21
▲ 3.01%Average
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)1,020.80
P/E915.83
P/B2.55
PEG—
ROE %0.29
ROCE %-2.00
Debt / Equity0.25
EPS0.12
Revenue Growth %6.70
Profit Growth %-96.20
Dividend Yield %0.45
Promoter Holding %74.89
FII Holding %0.03
DII Holding %—
Beta0.41
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 72% | ₹113.21 | ₹106.81 | ₹141.39 | 4.40 |
HOLDConviction 54%
The picture
- • Debt/Equity: 0.25
- • Promoter holding: 74.9%
- • RSI: 51
- • Price vs EMA21: above
- • Price vs SMA50: above
- • 1-month return: +11.3%
- • Pullback to 21-EMA signal (setup quality 72%)
Bull case
- • Debt/Equity: 0.25
- • Promoter holding: 74.9%
- • RSI: 51
- • Price vs EMA21: above
Bear case
- • Revenue growth: 6.7% YoY
- • Profit growth: -96.2% YoY
- • MACD: bearish
- • Bollinger position: 35% of band
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Weak fundamentals — technical strength may not sustain
- • Revenue growth: 6.7% YoY
- • Profit growth: -96.2% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹113.21
Stop Loss
₹107.27
risk 5.2%
Target 1 (1.5R)
₹122.13
+7.9%
Target 2 (3R)
₹131.04
+15.7%
Support (20d)
₹108.35
Resistance (52w)
₹148.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹5.94/share
ATR (volatility)
₹6.40
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹6.40). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
28
Technical
62
Momentum
80
Risk (safety)
38